AMPK activation by ozone therapy inhibits tissue factor‐triggered intestinal ischemia and ameliorates chemotherapeutic enteritis
Open Access
- 9 August 2020
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 34 (9) , 13005-13021
Abstract
Chemotherapeutic enteritis is a major dose‐limiting adverse reaction to chemotherapy, with few effective drugs in clinic. Intestinal ischemic injury plays prominent role in chemotherapeutic enteritis clinically. However, mechanism is not clear. In this article, irinotecan (CPT‐11) was used to establish chemotherapeutic enteritis mice model. Western blotting, gelatin zymography, immunohistochemistry (IHC), Laser Doppler flowmetry (LDF) were used to detect the pathogenesis of ischemia‐hypoxia injury. CPT‐11 increased levels of tissue factor (TF) both in the blood and in intestines, and decreased the intestinal blood flow in mice. Interestingly, the elevation of TF in the blood displayed “double‐peak,” which was consistent with the intestinal mucosal “double‐strike” injury trend. Intestinal microthrombus and mixed thrombus formation were detectable in chemotherapeutic enteritis. Furthermore, ozone therapy relieved chemotherapeutic enteritis in mice. Ozone inhibited TF expression induced by CPT‐11 via activating AMPK/SOCS3, and effectively ameliorated the intestinal mucosal injury in mice. Moreover, ozone autotransfusion therapy effectively attenuated chemotherapeutic enteritis and the blood hypercoagulability in patients. For the first time, we proposed that TF‐induced thrombotic intestinal ischemic injury is a core trigger pathological mechanism of chemotherapeutic enteritis, and provided a new treatment strategy, ozone therapy, to suppress TF expression and treat chemotherapeutic enteritis.Keywords
This publication has 39 references indexed in Scilit:
- The role of tissue factor in systemic inflammatory response syndromeBlood Coagulation & Fibrinolysis, 2011
- The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapyImmunological Reviews, 2007
- HIF-1α induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemiaJournal of Molecular and Cellular Cardiology, 2007
- SOCS proteins, cytokine signalling and immune regulationNature Reviews Immunology, 2007
- Prevention and Management of Chemotherapy-Induced Diarrhea in Patients with Colorectal Cancer: A Consensus Statement by the Canadian Working Group on Chemotherapy-Induced DiarrheaCurrent Oncology, 2007
- Ischämische Kolitis im Verlauf der Chemotherapie beim MammakarzinomDer Onkologe, 2006
- Chemotherapy-induced thrombosisThrombosis Research, 2006
- Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8Biochemical Journal, 2002
- Tissue factor is rapidly induced in arterial smooth muscle after balloon injury.Journal of Clinical Investigation, 1993
- In vitro Synergistic Activity of 5-Fluorouracil with Low-Dose Ozone against a Chemoresistant Tumor Cell Line and Fresh Human Tumor CellsChemotherapy, 1990